Dr. Rajarshi Bhadra, MD

Dr. Bhadra practices at Southwest Kidney Care in Albuquerque, New Mexico.

Dr. Bhadra's NPI, 1801341755, was assigned on August 22, 2016. Dr. Bhadra holds New Mexico license MD2021-0236.

Dr. Bhadra's primary practice is Southwest Kidney Care, at 5981 Jefferson NE St, Albuquerque, NM 87109 in Bernalillo County. The practice phone is (505) 370-9600.

Dr. Bhadra's primary practice is Southwest Kidney Care in Albuquerque, New Mexico. Dr. Bhadra is also affiliated with Presbyterian Hospital. The medical group on file is Southwest Kidney Care. Dmand AI also links Dr. Bhadra to 4 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhadra practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bhadra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bhadra is licensed in New Mexico.

CMS data shows 896 Medicare services from Dr. Bhadra across 8 procedure codes in 2024, for 266 Medicare patients. Medicare paid $89,024 for them.

CMS counts 266 Medicare patients who saw Dr. Bhadra in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhadra's median patient age at 69, with 49% women.

In 2024, Dr. Bhadra wrote 2,303 Medicare Part D claims for 310 patients. 82% of them were for generic drugs. CMS names the drug for 2,071 of them, across 45 drugs with 11 or more claims each, at $793,694 in total drug cost. In 2023, CMS named 2,344 claims across 47 drugs.

Dr. Bhadra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhadra as offering telehealth.

Dmand AI links 22 papers to Dr. Bhadra, published from 2011 to 2020. 2012 was the busiest year, with 4. The most frequent topics are CD8-Positive T-Lymphocytes, Toxoplasmosis and Toxoplasma. Dr. Bhadra has published most often in BMJ Case Rep. Dr. Bhadra's most frequent co-authors are Keyvan Ravakhah, MD, Raktim Kumar Ghosh, MD and Anjan Gupta, MD.

CMS Open Payments shows 66 general payments to Dr. Bhadra from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $264.